UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010845
Receipt No. R000012698
Scientific Title Phase II trial with abraxane and trastuzumab for advanced/recurrent HER2-positive breast cancer
Date of disclosure of the study information 2013/06/15
Last modified on 2013/05/31 11:13:24

No. Disposal Last modified on Item of update
1 Insert 2013/05/31 11:13:38


Contact us.